International Conference on Vasculitis and Inflammatory Diseases
(ICVID-26)

13th December 2026 || Bhubaneswar - India || Hybrid Mode

Proudly Organized by INRI

Join global experts to share ideas, connect, and innovate.
🎉 Coupon Copied Successfully!

Conference Session Tracks

The International Conference on Vasculitis and Inflammatory Diseases (ICVID), scheduled to be held on 13th December 2026 in Bhubaneswar, India, features a diverse range of session tracks covering key research areas, emerging trends and interdisciplinary innovations within the field of Rheumatology.

Each track offers researchers, academicians, industry professionals and practitioners a platform to present their work, exchange ideas and explore the advancements shaping the future of the domain. Every track is curated to encourage knowledge sharing, collaboration and meaningful discussion.

All Session Tracks
  • Track 01 – Advancements in Vasculitis Diagnosis
    This session will explore the latest methodologies in the diagnosis of vasculitis, emphasizing the role of molecular diagnostics and imaging techniques. Participants will discuss the integration of clinical findings with laboratory results to enhance diagnostic accuracy. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 4 – Quality Education
  • Track 02 – Immunological Mechanisms in Inflammatory Diseases
    This track will delve into the immunological pathways involved in various inflammatory diseases, particularly focusing on the role of cytokines and immune cell interactions. Researchers will present findings that elucidate the complex immune responses that drive disease progression. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 16 – Peace, Justice and Strong Institutions
  • Track 03 – Translational Research in Rheumatology
    This session aims to bridge the gap between laboratory research and clinical practice by highlighting translational studies in rheumatology. Attendees will examine case studies that illustrate successful applications of laboratory discoveries in patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 04 – Biomarkers in Vasculitis: Discovery and Application
    This track will focus on the identification and validation of biomarkers for vasculitis, discussing their potential roles in diagnosis, prognosis, and treatment response. Experts will share insights on the challenges and future directions in biomarker research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 05 – Therapeutic Strategies for Inflammatory Diseases
    This session will review emerging therapeutic strategies for managing inflammatory diseases, including novel pharmacological agents and biologics. Presenters will discuss the efficacy and safety profiles of these treatments in clinical settings. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 06 – Laboratory Techniques in Rheumatology Research
    This track will cover cutting-edge laboratory techniques utilized in rheumatology research, including advanced imaging and molecular biology methods. Participants will gain insights into how these techniques can enhance our understanding of disease mechanisms. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 07 – Clinical Management of Vasculitis Patients
    This session will focus on best practices and challenges in the clinical management of patients with vasculitis. Experts will share case studies and guidelines that inform treatment decisions and improve patient outcomes. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 08 – Pathophysiology of Inflammatory Diseases
    This track will explore the underlying pathophysiological mechanisms of various inflammatory diseases, with a focus on cellular and molecular interactions. Researchers will present their findings on how these mechanisms contribute to disease manifestation and progression. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 09 – Innovations in Clinical Trials for Rheumatology
    This session will highlight innovative approaches to designing and conducting clinical trials in rheumatology, emphasizing adaptive trial designs and patient-centered outcomes. Participants will discuss the implications of these innovations for future research. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
  • Track 10 – Patient Perspectives in Vasculitis Management
    This track will address the importance of incorporating patient perspectives into the management of vasculitis. Discussions will focus on patient-reported outcomes and the role of shared decision-making in treatment planning. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 10 – Reduced Inequalities
  • Track 11 – Future Directions in Vasculitis Research
    This session will provide a forward-looking perspective on the future of vasculitis research, including potential breakthroughs and emerging trends. Experts will discuss the implications of ongoing research for clinical practice and patient care. Aligned SDGs: SDG 3 – Good Health and Well-being  |  SDG 9 – Industry, Innovation and Infrastructure
Alignment with the Sustainable Development Goals
Alongside its academic focus, the conference promotes responsible research, ethical practice and knowledge-driven development. Its session tracks collectively contribute to the following United Nations Sustainable Development Goals.
  • SDG 3 SDG 3
    Good Health and Well-being
  • SDG 4 SDG 4
    Quality Education
  • SDG 9 SDG 9
    Industry, Innovation and Infrastructure
  • SDG 10 SDG 10
    Reduced Inequalities
  • SDG 16 SDG 16
    Peace, Justice and Strong Institutions

Need Assistance?

If you need any clarification on the session tracks or support with your submission, please feel free to reach out to us:

Email: [email protected]

Phone: +91 9677007228